Broadbent tapped as Xcellerex CEO

Guy Broadbent has been appointed president and CEO of Xcellerex and a member of the company's board of directors.
Affymax names John Orwin president and COO.
Bristol-Myers Squibb board elects Charles Bancroft CFO.
FORMA Therapeutics has announced that Robert Forrester has been appointed COO.
Somaxon Pharmaceuticals has appointed Tran Nguyen as VP and CFO.
KV Pharmaceutical has announced it has appointed Stephen Stamp as CFO and treasurer.
Luca Santarelli has been named head of the Central Nervous System (CNS) Discovery and Translational Area at Roche.
Dipak Panigrahi will join QLT as SVP, R&D and chief medical officer.
Inspire Pharmaceuticals will name Andrew Koven to the newly created position of EVP and chief administrative and legal officer, effective May 10, 2010.

Add new comment

Images
More information
  • Files must be less than 2 MB.
  • Allowed file types: png gif jpg jpeg.
Documents
More information
  • Files must be less than 2 MB.
  • Allowed file types: zip rar.